|
|
 |
|
Viewing report
|
|
|
|
Financial Markets Research: Bausch & Lombs Contact Lens Solution Withdrawal - ReNu MultiPlus Likely to Struggle in Attempt to Regain Market Share
Datamonitor, Aug 2006, Pages: 12
In May 2006 Bausch & Lombs ReNu with MoistureLoc contact lens solution was permanently withdrawn from markets worldwide due to an outbreak of a fungal eye infection. For a large market player, the loss of a new revenue driver and the negative publicity surrounding the event is likely to have a significant impact on future success, as well as implications for other companies in the sector.
Scope of this title:
- This report analyzes the market outlook in the aftermath of the withdrawal of Bausch & Lombs ReNu with MoistureLoc contact lens solution
- We interviewed eight optometrists from the US and the EU in the course of research
Highlights of this title:
- Bausch & Lombs explanation of the cause of infection is in line with suspicions of interviewed optometry experts that the revolutionary make-up of MoistureLocs formula made it susceptible to external factors that could elevate infection risk.
- Moving forward, US practitioners will likely put more emphasis on patient adherence to particular recommended brands, and patients are likely to be less price-sensitive, favoring competitors over Bausch & Lombs older contact lens solution, ReNu MultiPlus.
- Collateral damage to Bausch & Lombs eye care franchise in European markets is expected to be minimal.
Reasons to order your copy:
- Understand the implications of Bausch & Lombs product recall through in-depth analysis based on interviews with leading experts
- Anticipate likely changes in the future market dynamics for contact lens solutions following the withdrawal of ReNu with MoistureLoc
Customers who bought this item also bought
Bausch & Lomb Incorporated - Healthcare - Medical Equipment SWOT Report
Bausch & Lomb Incorporated Product Pipeline Analysis
Bausch & Lomb Incorporated Medical Equipment Company Share Analysis 2008
Contact Lenses and Solutions - Global Strategic Business Report
Bausch & Lomb Incorporated - Strategic Analysis Review
Bausch & Lomb Incorporated
Bausch & Lomb Incorporated - SWOT Analysis
Bausch & Lomb Incorporated Medical Equipment Company Share Analysis
Intra Ocular Lens (IOL) Clinical Trial Analysis
Glasses and Contact Lenses in the United States
Eye Glasses & Contact Lens Stores in the US
The 2007-2012 Outlook for Eye and Ear Preparations and Contact Lens Solutions Excluding Anti-Infective Corticoids, Antibacterials, and Antiseptics in India
|
|
|
|
